← Oncology Approval Tracker

FDA DECISION ·

Afatinib tablets

afatinib dimaleate · Hetero Labs / Apotex

First generic approvalFirst genericNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generics of Gilotrif for first-line metastatic NSCLC with qualifying non-resistant EGFR mutations, and for metastatic squamous NSCLC progressing after platinum-based chemotherapy.

LAMPGEN ANALYSIS

Why it matters

These approvals add generic options for afatinib tablets. Separate the two lung cancer uses, which have different biomarker and prior-treatment requirements.

What research teams should watch

Record the approved product, exact EGFR result when applicable, and distribution availability. Check site formularies before attributing any access change to the approval.

PRIMARY RECORDS

Sources